NLRP3 inflammasome-mediated premature immunosenescence drives diabetic vascular aging dependent on the induction of perivascular adipose tissue dysfunction.

Guang-Jie Tai, Yan-Jie Ma, Jun-Lin Feng, Jia-Peng Li, Shu Qiu, Qing-Qing Yu, Ren-Hua Liu, Silumbwe Ceaser Wankumbu, Xin Wang, Xiao-Xue Li, Ming Xu

Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tong jia Lane, Nanjing 210009, China.Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tong jia Lane, Nanjing 210009, China. · pubmed

Paper

Abstract

The vascular aging process accelerated by type 2 diabetes mellitus (T2DM) is responsible for the elevated risk of associated cardiovascular diseases. Metabolic disorder-induced immune senescence has been implicated in multi-organ/tissue damage. Herein, we sought to determine the role of immunosenescence in diabetic vascular aging and to investigate the underlying mechanisms.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that NLRP3 inflammasome-mediated immunosenescence contributes to diabetic vascular aging through perivascular adipose tissue dysfunction. This research is relevant as it addresses mechanisms underlying aging processes, specifically immunosenescence, which is a significant factor in age-related diseases and longevity.

Author of this paper? Send a correction.